Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2017 3
2018 6
2019 4
2020 5
2021 12
2022 11
2023 19
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Reappraisal of Linezolid Dosing in Renal Impairment To Improve Safety.
Crass RL, Cojutti PG, Pai MP, Pea F. Crass RL, et al. Among authors: cojutti pg. Antimicrob Agents Chemother. 2019 Jul 25;63(8):e00605-19. doi: 10.1128/AAC.00605-19. Print 2019 Aug. Antimicrob Agents Chemother. 2019. PMID: 31109977 Free PMC article.
Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring.
Cojutti PG, Tedeschi S, Gatti M, Zamparini E, Meschiari M, Siega PD, Mazzitelli M, Soavi L, Binazzi R, Erne EM, Rizzi M, Cattelan AM, Tascini C, Mussini C, Viale P, Pea F. Cojutti PG, et al. Antibiotics (Basel). 2022 Jul 24;11(8):996. doi: 10.3390/antibiotics11080996. Antibiotics (Basel). 2022. PMID: 35892386 Free PMC article.
Impact of a newly established expert clinical pharmacological advice programme based on therapeutic drug monitoring results in tailoring antimicrobial therapy hospital-wide in a tertiary university hospital: Findings after the first year of implementation.
Cojutti PG, Gatti M, Bonifazi F, Caramelli F, Castelli A, Cavo M, Cescon M, Corvaglia LT, Lanari M, Marinelli S, Morelli MC, Pession A, Poggioli G, Ramirez S, Siniscalchi A, Tonetti T, Trevisani F, Zanoni A, Zinzani PL, Gibertoni C, Viale P, Pea F. Cojutti PG, et al. Int J Antimicrob Agents. 2023 Aug;62(2):106884. doi: 10.1016/j.ijantimicag.2023.106884. Epub 2023 Jun 10. Int J Antimicrob Agents. 2023. PMID: 37302773 Free article.
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections.
Gatti M, Viale P, Cojutti PG, Zamparini E, De Paolis M, Giannella M, Pea F, Tedeschi S. Gatti M, et al. Among authors: cojutti pg. Int J Antimicrob Agents. 2023 May;61(5):106773. doi: 10.1016/j.ijantimicag.2023.106773. Epub 2023 Mar 4. Int J Antimicrob Agents. 2023. PMID: 36878410
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia.
Gatti M, Pascale R, Cojutti PG, Rinaldi M, Ambretti S, Conti M, Tedeschi S, Giannella M, Viale P, Pea F. Gatti M, et al. Among authors: cojutti pg. Int J Antimicrob Agents. 2023 Jan;61(1):106699. doi: 10.1016/j.ijantimicag.2022.106699. Epub 2022 Dec 2. Int J Antimicrob Agents. 2023. PMID: 36464151
[Pharmacogenetics of immunosuppressants].
Cojutti PG, Baraldo M. Cojutti PG, et al. G Ital Nefrol. 2015 Mar-Apr;32(2):gin/32.2.27. G Ital Nefrol. 2015. PMID: 26005938 Italian.
56 results